United States:
D. Mass. Patent Litigation Update, September 2023
03 November 2023
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
To print this article, all you need is to be registered or login on Mondaq.com.
This is part of a series of articles discussing recent
orders of interest issued in patent cases by the United States
District Court for the District of Massachusetts.
In ModernaTX, Inc. v. Pfizer
Inc., No. 1:22-cv-11378, Judge Stearns granted
Moderna's motion to compel Defendants to respond to
interrogatories and detail (i) their knowledge of the nature of
Moderna's work in the mRNA vaccine space and (ii) state the
date on which they first became aware of the patent.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
Are Your NDAs Up To Date?
Wolf, Greenfield & Sacks, P.C.
Nondisclosure agreements (NDAs) can be used to protect companies' confi dential and trade secret information. But you should resist the urge to have a vendor...
Legal Implications Of New York Times vs. OpenAI
BoyarMiller
The New York Times recently filed a landmark lawsuit against OpenAI and Microsoft, accusing them of copyright infringement in the training of the chatbot ChatGPT which launched just over a year ago.
